Rohan Palekar - Dec 29, 2023 Form 4 Insider Report for 89bio, Inc. (ETNB)

Signature
/s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar
Stock symbol
ETNB
Transactions as of
Dec 29, 2023
Transactions value $
-$463,500
Form type
4
Date filed
1/3/2024, 04:54 PM
Previous filing
Aug 21, 2023
Next filing
Jan 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $96.5K +50K +16.6% $1.93 351K Dec 29, 2023 Direct F1
transaction ETNB Common Stock Sale -$560K -50K -14.24% $11.20 301K Dec 29, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -50K -25.61% $0.00 145K Dec 29, 2023 Common Stock 50K $1.93 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes an aggregate of 275 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2023.
F2 This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023.
F3 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.035 to $11.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F4 This option is vested in full.